CSIMarket
 


Akers Biosciences Inc   (AKER)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare
 

AKER's Revenue Growth by Quarter and Year

Akers Biosciences Inc 's Revenue results by quarter and year




AKER Revenue (in millions $) FY 2020 FY 2019 FY 2018 FY 2017
IV Quarter December - 0.08 0.28 0.81
III Quarter September - 0.42 0.56 0.68
II Quarter June - 0.46 0.53 1.07
I Quarter March 0.36 0.61 0.30 0.67
FY   0.36 1.57 1.67 3.23



AKER Revenue first quarter 2020 Y/Y Growth Comment
Akers Biosciences Inc reported fall in Revenue in the first quarter by -40.41% to $ 0.36 millions, from the same quarter in 2019.
The drop in the first quarter Akers Biosciences Inc 's Revenue compares unfavorably to the Company's average Revenue decrease of -4.36%.

Looking into first quarter results within Biotechnology & Drugs industry 78 other companies have achieved higher Revenue growth. While Akers Biosciences Inc ' s Revenue drop of -40.41% ranks overall at the positon no. 2861 in the first quarter.




AKER Revenue ( Y/Y Growth %) 2020
2019 2018 2017
IV Quarter December - -71.43 % -65.43 % 24.62 %
III Quarter September - -25 % -17.65 % 11.48 %
II Quarter June - -13.21 % -50.47 % 11.46 %
I Quarter March -40.41 % 103.33 % -55.22 % -9.46 %
FY   - -5.99 % -48.3 % 9.12 %

Financial Statements
Akers Biosciences Inc 's first quarter 2020 Revenue $ 0.36 millions AKER's Income Statement
Akers Biosciences Inc 's first quarter 2019 Revenue $ 0.61 millions Quarterly AKER's Income Statement
New: More AKER's historic Revenue Growth >>


AKER Revenue (Quarter on Quarter Growth %)

2020
2019 2018 2017
IV Quarter December - -80.95 % -50 % 19.12 %
III Quarter September - -8.7 % 5.66 % -36.45 %
II Quarter June - -24.59 % 76.67 % 59.7 %
I Quarter March 354.39 % 117.86 % -62.96 % 3.08 %
FY (Year on Year)   - -5.99 % -48.3 % 9.12 %




Revenue first quarter 2020 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #79
Healthcare Sector #413
Overall #2861

Revenue Y/Y Growth Statistics
High Average Low
19.02 % -4.36 % -31.62 %
(Sep 30 2016)   (Dec. 30, 2015)
Revenue first quarter 2020 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #79
Healthcare Sector #413
Overall #2861
Revenue Y/Y Growth Statistics
High Average Low
19.02 % -4.36 % -31.62 %
(Sep 30 2016)   (Dec. 30, 2015)

Revenue by Quarter for the Fiscal Years 2017, 2018, 2019, 2020

Akers Biosciences Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
356.76 % 29.97 % -82.47 %
(Mar 31 2020)  


AKER's I. Quarter Q/Q Revenue Comment
Akers Biosciences Inc achieved in the I. Quarter 2020 above company average sequential Revenue doubling of 354.39%, to $ 0.36 millions, from $0.08 millions in the forth quarter.
Biotechnology & Drugs company is undergoing a remarkable growth, with reporting better then normal increase, and also accelerating speed.

Within Biotechnology & Drugs industry 5 other companies have achieved higher Revenue quarter on quarter growth. While Akers Biosciences Inc 's Revenue growth quarter on quarter, overall rank is 33.


Revenue Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #6
Healthcare Sector #14
Overall #33
Revenue Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #6
Healthcare Sector #14
Overall #33
Revenue Q/Q Growth Statistics
High Average Low
356.76 % 29.97 % -82.47 %
(Mar 31 2020)  


AKER's I. Quarter Q/Q Revenue Comment
Akers Biosciences Inc achieved in the I. Quarter 2020 above company average sequential Revenue doubling of 354.39%, to $ 0.36 millions, from $0.08 millions in the forth quarter.
Akers Biosciences Inc is impressively improving, with reporting better then regular growth, and also accelerating speed.

Within Biotechnology & Drugs industry 5 other companies have achieved higher Revenue quarter on quarter growth. While Akers Biosciences Inc 's Revenue growth quarter on quarter, overall rank is 33.


Akers Biosciences Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Mar 31 2020)
12 Months Ending
(Dec 31 2019)
12 Months Ending
(Sep 30 2019)
12 Months Ending
(Jun 30 2019)
12 Months Ending
(Mar 31 2019)
Cumulative Revenue 12 Months Ending $ 1.33 $ 1.58 $ 1.78 $ 1.91 $ 1.98
Y / Y Revenue Growth (TTM) -32.75 % -5.32 % -19.23 % -17.49 % -31.06 %
Year on Year Revenue Growth Overall Ranking # 2642 # 2753 # 2360 # 3137 # 3210
Seqeuential Revenue Change (TTM) -15.76 % -11.25 % -7.12 % -3.14 % 18.59 %
Seq. Revenue Growth (TTM) Overall Ranking # 2861 # 3437 # 2956 # 3062 # 202




Cumulative Revenue growth Comment
Akers Biosciences Inc 's cumulative 12 months Revenue continue to drop, but on the faster rate at -32.75% year on year, at Mar 31 2020 compare to the -5.32% decrease at Dec 31 2019. If the Akers Biosciences Inc 's fiscal year would end at Mar 31 2020, annual Revenue would be $1 millions.

In the Healthcare sector 341 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 2642, from total ranking in previous quarter at 2753.

Revenue TTM Q/Q Growth Statistics
High Average Low
19.02 %
-4.36 %
-31.62 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry # 79
Healthcare Sector # 342
Overall # 2642

Revenue TTM Y/Y Growth Statistics
High Average Low
39.99 %
-9.11 %
-52.23 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 79
Sector # 413
S&P 500 # 2861
Cumulative Revenue growth Comment
Akers Biosciences Inc 's cumulative 12 months Revenue continue to drop, but on the faster rate at -32.75% year on year, at Mar 31 2020 compare to the -5.32% decrease at Dec 31 2019. If the Akers Biosciences Inc 's fiscal year would end at Mar 31 2020, annual Revenue would be $1 millions.

In the Healthcare sector 341 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 2642, from total ranking in previous quarter at 2753.

Revenue TTM Q/Q Growth Statistics
High Average Low
19.02 %
-4.36 %
-31.62 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry # 79
Healthcare Sector # 342
Overall # 2642

Revenue TTM Y/Y Growth Statistics
High Average Low
39.99 %
-9.11 %
-52.23 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 79
Sector # 413
S&P 500 # 2861




Other Revenue Growth
Biotechnology & Drugs Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
AKER's Revenue Growth Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for AKER's Competitors
Revenue Growth for Akers Biosciences Inc 's Suppliers
Revenue Growth for AKER's Customers

You may also want to know
AKER's Annual Growth Rates AKER's Profitability Ratios AKER's Asset Turnover Ratio AKER's Dividend Growth
AKER's Roe AKER's Valuation Ratios AKER's Financial Strength Ratios AKER's Dividend Payout Ratio
AKER's Roa AKER's Inventory Turnover Ratio AKER's Growth Rates AKER's Dividend Comparisons



Companies with similar Revenue drop for the quarter ending Mar 31 2020 within Healthcare SectorY/Y Change %Revenue for the quarter ending Mar 31 2020
Regenerx Biopharmaceuticals Inc -0.01 %$ -0.005 millions
Seaspine Holdings Corporation -0.11 %$ -0.108 millions
Bausch Health Companies Inc -0.20 %$ -0.198 millions
Abiomed Inc -0.20 %$ -0.204 millions
Mei Pharma Inc -0.40 %$ -0.400 millions
Tenet Healthcare Corp -0.55 %$ -0.550 millions
Mednax Inc -0.62 %$ -0.619 millions
Icu Medical Inc -0.70 %$ -0.703 millions
Neos Therapeutics Inc -0.96 %$ -0.964 millions
Hanger Inc -1.13 %$ -1.134 millions
Atricure Inc -1.37 %$ -1.373 millions
Integra Lifesciences Holdings Corp -1.49 %$ -1.492 millions
Spine Injury Solutions Inc -1.55 %$ -1.550 millions
Cryolife Inc -1.59 %$ -1.594 millions
United Therapeutics Corporation -1.74 %$ -1.737 millions
Conmed Corporation -2.00 %$ -2.000 millions
Invacare Corporation -2.23 %$ -2.229 millions
Lifeloc Technologies Inc -2.44 %$ -2.437 millions
Allied Healthcare Products Inc -2.63 %$ -2.631 millions
U S Physical Therapy Inc -3.02 %$ -3.023 millions
Icad Inc -3.19 %$ -3.189 millions
Integrated Biopharma Inc -3.24 %$ -3.244 millions
Livanova Plc -3.35 %$ -3.351 millions
Cardiovascular Systems Inc -3.37 %$ -3.374 millions
Sientra Inc -3.53 %$ -3.532 millions
Accuray Incorporated -3.56 %$ -3.558 millions
Quest Diagnostics Inc -3.65 %$ -3.649 millions
Harrow Health Inc -3.85 %$ -3.849 millions
Fonar Corp -3.89 %$ -3.891 millions
Nanostring Technologies Inc -3.91 %$ -3.911 millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

GPN's Profile

Stock Price

GPN's Financials

Business Description

Fundamentals

Charts & Quotes

GPN's News

Suppliers

GPN's Competitors

Customers & Markets

Economic Indicators

GPN's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071